NEW YORK (Reuters) - Prosecutors are seeking about $1 billion to resolve a long-standing probe into Johnson & Johnson's marketing of its Risperdal anti-psychotic medicine, the Wall Street Journal said on Thursday, citing sources familiar with the matter.
Johnson & Johnson in a regulatory filing earlier this week said it had set aside an unspecified amount of money for a potential settlement of the probe into whether the company promoted Risperdal for unapproved uses.
Prosecutors are pushing J&J to reach a settlement soon, the Journal said on Thursday, citing one source.
J&J officials could not immediately be reached for comment.
A spokeswoman for the Attorney's Office in Philadelphia declined to comment on the report.
(Reporting by Ransdell Pierson; Editing by Richard Chang)
Relacionados
- El Alcalde de Lorca hace un llamamiento pidiendo ayuda
- Herrera considera que la foto del etarra pidiendo el voto a Bildu es un "gol en propia puerta" del Gobierno
- Bildu.- Bono dice que le "subleva" la foto del etarra pidiendo el voto y que es una "prueba" de que "no se arrepienten"
- ETA.- Zapatero dice que "hace días" que leyó la carta de Currin pidiendo una verificación internacional
- 22-M.- Candidato del PP cree que Zapatero debería ir a Cantabria "de rodillas y pidiendo perdón" por los recortes
